Cidara Therapeutics (CDTX) Tops Q1 EPS by 9c

Cidara Therapeutics (NASDAQ: CDTX) reported Q1 EPS of $0.03, $0.09 better than the analyst estimate of ($0.06). Revenue for the quarter came in at $25.99 million versus the consensus estimate of $16.25 million.

For earnings history and earnings-related data on Cidara Therapeutics (CDTX) click here.

You May Also Be Interested In

• Micron offers Taiwan workers up to 68-month bonuses as strike threat looms
• GE Vernova (GEV) PT Raised to $1,185 at Jefferies
• Roblox announces standalone apps, browser play, and creator wallet